An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen

Published:2023-11-10 Issue: Volume:10 Page:59-66
ISSN:2331-4737
Container-title:Oncoscience
language:en
Short-container-title:Oncoscience

Author:

Cheng Peter¹,Cios Konrad J.¹,Varkhedi Mallika¹,Barker Vayda R.¹,Yeagley Michelle¹,Chobrutskiy Andrea²,Chobrutskiy Boris I.³,Blanck George¹⁴

Affiliation:

1. Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida (FL) 33612, USA

2. Department of Pediatrics, Oregon Health and Science University Hospital, Portland, Oregon (OR) 97239, USA

3. Department of Internal Medicine, Oregon Health and Science University Hospital, Portland, Oregon (OR) 97239, USA

4. Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida (FL) 33612, USA

Publisher

Impact Journals, LLC

Subject

Cancer Research,Oncology

Reference31 articles.

1. Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015; 21:7933–43. https://doi.org/10.3748/wjg.v21.i26.7933. PMID:26185366

2. Baba Y, Nomoto D, Okadome K, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Baba H. Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma. Cancer Sci. 2020; 111:3132–41. https://doi.org/10.1111/cas.14541. PMID:32579769

3. Yagi T, Baba Y, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Baba H. PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer. Ann Surg. 2019; 269:471–78. https://doi.org/10.1097/SLA.0000000000002616. PMID:29206673

4. Zhang Y, Zhang Y, Zhang L. Expression of cancer-testis antigens in esophageal cancer and their progress in immunotherapy. J Cancer Res Clin Oncol. 2019; 145:281–91. https://doi.org/10.1007/s00432-019-02840-3. PMID:30656409

5. Bhat AA, Nisar S, Maacha S, Carneiro-Lobo TC, Akhtar S, Siveen KS, Wani NA, Rizwan A, Bagga P, Singh M, Reddy R, Uddin S, Grivel JC, et al. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy. Mol Cancer. 2021; 20:2. https://doi.org/10.1186/s12943-020-01294-3. PMID:33390169

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3